Aldeyra Therapeutics, Inc.

ALDX

$1.21

Name : Aldeyra Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $72,693,336.00

EPSttm : -0.38

Aldeyra Therapeutics, Inc.

$1.21

1.23%

$0.015

ALDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.2

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

-0.01

EPS Last/This Y

0.22

EPS This/Next Y

0.06

Price

1.2

Target Price

6.6

Analyst Recom

1.4

Performance Q

-34.15

Upside

-1,199.2%

Beta

1.19

Ticker: ALDX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	ALDX	1.48	0.12	0.41	14370
2026-08-31	ALDX	1.49	0.08	0.11	13545
2026-09-02	ALDX	1.5	0.08	0.07	13641
2026-09-03	ALDX	1.49	0.08	0.01	13726
2026-09-04	ALDX	1.5	0.08	0.02	14137
2026-09-08	ALDX	1.55	0.08	0.02	13282
2026-09-09	ALDX	1.505	0.08	0.04	13429
2026-09-10	ALDX	1.46	0.08	0.58	13398
2026-09-11	ALDX	1.34	0.08	0.68	13441
2026-09-14	ALDX	1.47	0.07	0.08	12502
2026-09-15	ALDX	1.38	0.07	4.90	12564
2026-09-16	ALDX	1.38	0.08	0.06	12673
2026-09-17	ALDX	1.395	0.08	0.02	13200
2026-09-18	ALDX	1.355	0.08	0.04	13220
2026-09-21	ALDX	1.355	0.13	0.05	6025
2026-09-22	ALDX	1.395	0.12	0.30	6243
2026-09-23	ALDX	1.34	0.12	0.04	6293
2026-09-24	ALDX	1.23	0.12	0.33	6409
2026-09-25	ALDX	1.2	0.12	0.08	6568
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	ALDX	1.49	28.9	-	-0.34
2026-08-31	ALDX	1.49	28.9	-	-0.34
2026-09-01	ALDX	1.49	28.9	-	-0.34
2026-09-02	ALDX	1.50	28.9	-	-0.34
2026-09-03	ALDX	1.48	28.9	-	-0.34
2026-09-04	ALDX	1.48	28.9	-	-0.34
2026-09-08	ALDX	1.54	28.9	-	-0.34
2026-09-09	ALDX	1.50	28.9	-	-0.34
2026-09-10	ALDX	1.47	28.9	-	-0.34
2026-09-11	ALDX	1.35	28.9	-	-0.34
2026-09-14	ALDX	1.47	28.9	-	-0.34
2026-09-15	ALDX	1.38	28.9	-	-0.34
2026-09-16	ALDX	1.38	28.9	-	-0.34
2026-09-17	ALDX	1.39	28.9	-	-0.34
2026-09-18	ALDX	1.35	28.9	-	-0.34
2026-09-21	ALDX	1.35	28.9	-	-0.34
2026-09-22	ALDX	1.39	28.9	-	-0.34
2026-09-23	ALDX	1.34	28.9	-	-0.34
2026-09-24	ALDX	1.23	28.9	-	-0.34
2026-09-25	ALDX	1.20	28.9	-	-0.34
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	ALDX	17.04	-2.87	5.72
2026-08-31	ALDX	17.04	-3.57	5.72
2026-09-01	ALDX	17.04	-3.57	5.72
2026-09-02	ALDX	17.04	-3.57	5.72
2026-09-03	ALDX	17.04	-3.57	5.72
2026-09-04	ALDX	17.04	-3.57	5.72
2026-09-08	ALDX	17.04	-3.55	5.72
2026-09-09	ALDX	17.04	-3.55	5.72
2026-09-10	ALDX	17.04	-3.55	5.72
2026-09-11	ALDX	17.04	-3.55	5.37
2026-09-14	ALDX	17.04	-3.89	5.37
2026-09-15	ALDX	17.04	-3.89	5.37
2026-09-16	ALDX	17.04	-3.89	5.37
2026-09-17	ALDX	17.04	-3.89	5.37
2026-09-18	ALDX	17.04	-3.89	5.37
2026-09-21	ALDX	12.61	-3.89	5.37
2026-09-23	ALDX	12.61	-3.89	5.37
2026-09-24	ALDX	12.61	-3.89	5.37
2026-09-25	ALDX	12.61	-3.89	6.20
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

12.61

Institutional Transactions

-3.89

Beta

1.19

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-89.7

Target Price

6.6

P/E

Forward P/E

PEG

P/S

P/B

1.92

P/Free Cash Flow

EPS

-0.38

Average EPS Est. Cur. Y

-0.34

EPS Next Y. (Est.)

-0.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.57

Return on Equity vs Sector %

-87.1

Return on Equity vs Industry %

-67.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

◆ ALDX Healthcare

$1.21

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

19/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

30.4

Range 1M

5.3%

Sup Dist

2.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

20/30

Estimates

0/20

Inst/Vol

0/15

Options

10/10

EPS Yr

39.3%

EPS NY

18.2%

52W%

3.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +445.5% upside

Quality

3/30

Valuation

16/30

Growth

16/25

Stability

7/10

LT Trend

4/5

Upside

+445.5%

Quality

ALDX — P/E HistoricalBiotechnology

Aldeyra Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 6

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

ALDX

Latest News

—

Caricamento notizie per ALDX…

stock quote shares ALDX – Aldeyra Therapeutics, Inc. Stock Price stock today

news today ALDX – Aldeyra Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALDX – Aldeyra Therapeutics, Inc. yahoo finance google finance

stock history ALDX – Aldeyra Therapeutics, Inc. invest stock market

stock prices ALDX premarket after hours

ticker ALDX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ALDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y